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Abstract
Background: Sentinel lymph node (SLN) detection and biopsy is gaining popularity in the treatment of Head and
Neck cancer. Various methods in this regard have been described, each with their respective advantages and
disadvantages. The aim of this paper was to evaluate the potential application of Indocyanin Green (ICG) in the
mapping and detection of sentinel lymph nodes (SLN) in cancers of the head and neck.
Methods: Patients with oropharyngeal cancer and N0 neck who were scheduled for primary tumor ablation as
well as a neck dissection were selected. One milliliter of Indocyanin green was injected around the tumor and the
sentinel node detection was performed by aiming the infra red video camera on the cervical area. When no
detection was possible transcutaneously, a cervical incision was made, a sub-platysmal flap raised and further
detection was done to visualize the fluorescing lymph nodes.
Results: Detection of cervical SLN was only possible when 5 mm or less tissue covered the sentinel lymph node.
Accurate and clear detection of the lymph drainage pattern and SLN was possible. There is some uptake in other
tissues such as the submandibular gland which is easily distinguishable from lymphatic tissue.
Conclusion: Indocyanin green fluorescence is a potential valuable potential tool in the detection of SLN in
patients with oropharyngeal cancer which warrants further investigation.
Background
It is well known that poorer prognosis prevails in head
and neck cancer patients that develop metastatic lymph
nodes and even more so if there is evidence of extra
capsular spread. This is one of the reasons why elective
neck dissections are frequently performed even in
patients with N0 necks [1].
There are no clear and accurate guidelines regarding
the decision to perform a neck dissection concurrent to
the ablation of the primary tumor in the N0 neck. Clini-
cal staging of the neck by manual examination is notor-
iously inaccurate, especially in patients with more
voluminous necks. Radiological staging with either CT
or MRI has improved the sensitivity for identifying
nodal metastatic disease and has contributed to the
upstaging of necks in a significant number of patients,
resulting in a more accurate selection of patients requir-
ing a neck dissection. With size alone as one of the
more important criteria in this regard it has been shown
that an important group of patients at risk for occult
lymphatic metastasis may be missed [2,3].
The potential benefit of CT-PET in the pre operative
evaluation of patients with a negative CT or MRI is still
controversial and probably plays a bigger role in detect-
ing second primary tumors and follow up [4,5].
Ultrasound with simultaneous fine needle aspiration
cytology is probably the most accurate method to date
in staging the neck, but requires skill and solid ultra-
sound and cytology knowledge to reach good levels of
accuracy [6].
Currently there is thus no accurate way of determin-
ing the presence of occult lymphatic metastasis for can-
cers of the head and neck. It is clear that the gold
standard for detecting involved lymph nodes is accurate
pathological analysis of the no d e s .T h i si st r a d i t i o n a l l y
done in a retrospective manner by sending the neck
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logical processing there is a possibility to miss micro
metastases as the specimens are not as accurately
examined as with a sentinel node protocol. In such a
protocol stepwise serial sectioning as well as immuno-
histochemistry will be able to find occult microscopic
deposits that would be missed with routine pathology
examinations [7].
Many factors determine the propensity of a tumor to
disseminate its cells to spread via the anatomical lym-
phatic system. Tumor cell motility as well as lymphatic
vessel density is factors that may contribute to the
enhanced spread along lymphatic pathways [8].
The principle of sentinel lymph node (SLN) identifica-
tion and biopsy is to identify the first station of drainage
of a particular anatomical area in which the tumor lies
[9,10].
SLN detection was first used in other anatomical areas
like the breast and soon skin cancer as well as gastric
cancers followed. In many centers SLN detection has
become standard clinical practice.
Benefits for the patients are the more selective
removal of the first drainage lymph nodes from a parti-
cular anatomical site with lower morbidity and by closer
histological examination of the nodes a higher detection
rate of micro metastasis is possible.
The anatomical basis of head and neck cancer nodal
drainage has been well established and is in use on a
d a i l yb a s i s[ 1 1 ] .O nt h i sb a s i st h et y p ea sw e l le x t e n to f
the neck dissection is determined [12]. For a long time
the head and neck area has escaped the concept of sen-
tinel neck dissection due to the conceived variability in
the lymph drainage from the oropharyngeal area. In
recent years this concept has made way for increasing
interest in the potential benefits in patients with oro-
pharyngeal cancer.
SLN identification and biopsy has increased its role in
detection of the first nodal drainage in an attempt to
either limit surgical damage, or to more accurately stage
the patient by more accurate examination of the sentinel
node or nodes. Koch et al (1998) was the first to describe
the use of technesium-99 m (99T cm) labeled sulfur col-
loid in the quest for accurate sentinel node biopsy [13].
The use of lymphoscyntography with 99T cm colloid
as well as a following SLN biopsy with possible concur-
rent blue dye injection can be regarded as the current
gold standard with regards to identification of the SLN
[14]. With this technique there is no direct visualization
of the lymph drainage pattern, but only indirect visuali-
zation of the SLN with the gamma probe. Indocyanin
Green (ICG) has been used extensively in the medical
field since 1957 [15]. Initial uses were for blood flow
measurements, but of late one of the mainstay uses is
for retinal angiography, especially in the diagnosis of
wet age related macular degeneration. As soon as ICG is
infused intravenously, it rapidly binds to plasma proteins
and thereby is confined to the vascular space. ICG is
removed exclusively by the liver at the rate of 18-24%
per minute so the elimination of ICG follows an expo-
nential curve with a half-life of ~150-180 s [16].
The use of ICG in the diagnosis of SLN in areas other
than that of the head and neck region has well been
described. Reports of its use in gastric, breast, lung as
well as skin cancer are found in the literature with good
success [17-22]
Methods
A total of 8 Patients with oropharyngeal head and neck
cancer and N0 neck status and where resection of the
primary tumor as well as a neck dissection was planned
were used to evaluate the use of ICG in the identifica-
tion of the sentinel lymph node. Only unilateral elective
neck dissections were performed according to the clini-
cal indication. In no way was the treatment of the
patients altered or influenced by the additional use of
ICG or sentinel node detection. Patient’si n f o r m e dc o n -
sent was obtained before surgery.
ICG (®ICG-Pulsion, Pulsion medical Systems AG, Ger-
many)is supplied as a sterile, water-soluble powder dye
(Figure 1) that is used clinically as a dilution indicator
for studies involving the heart, liver, lungs, and circula-
tion as well as for ophthalmic angiography.
ICG contains sodium iodide and should be used with
caution in patients who have a history of allergy to
iodides.
All patients were treated under general anesthesia.
Standard nasal or tracheotomy intubation was per-
formed. A solution of ICG is made up by diluting 50
mg ICG powder with 5 ml aqueous water. The proposed
mucosal resection margins are marked with superficial
diathermy or CO2 laser points for the possibility of
mucosal color changes after the ICG injection. Along
the circumference of the tumor one milliliter of ICG
solution was injected with at least five injection points.
Special care has to be taken to prevent spill around the
tumor area as well as contamination on gloves that may
be transferred to the skin that will result in inappropri-
ate light reaction in unaffected areas and interpretation
of the signal. The infra red video camera (®PDE-Photo-
dynamic Eye, Hamamatsu Photonics Deutschland
GmbH) was then directed to the cervical area within 3-
5 minutes and an attempt was made to identify the sen-
tinel lymph node. (Figure 2) There are three possibilities
to adjust the camera to gain optimal visualization and
identification of the sentinel node, namely brightness,
infrared and contrast.
Due to poor initial experiences with the trans-cutaneous
visualization a sub-platysmal flap was raised and the
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red camera was directed to the area. Time from injection
to identification was more than 30 minutesinitially, but
brought down to 5 minutes or less in the latter cases
where the lymphatic drainage pattern could be seen in real
time on the video screen.
The lymph drainage pattern was noted and sentinel
node or nodes were marked and sent separately for sen-
tinel node pathological examination.
All the sentinel nodes were marked and sent to the
pathologist for evaluation according to a sentinel node
protocol. The planned neck dissection was then com-
pleted as planned.
Results
In total 8 patients with oropharyngeal cancer (Figure 3)
and N0 necks were subjected to the added investigation
as described. In all cases the sentinel node or nodes
could be identified and sent for separate, more intense
pathological identification. The number of sentinel
lymph nodes varied from one to 5 with an average of 3.
In one patient with a maxillary tumor the sentinel node
was positive with a micro metastasis present.
Identification of the SLN takes some getting used to
as the node has to be exposed to some extent before the
light reaction can be visualized through the infra red
video camera. All cases where identification was
attempted through the skin were unsuccessful. There-
after the skin incision and exposure of the neck in a
sub-platysma muscle level and exposure of the levels IA
and IB with an attempt to identify the first station of
lymph drainage followed. (Figure 4) In the next step the
Sternocleidomastoid muscle was retracted and the Jugu-
lodigastric lymph nodes were evaluated by the Infra red
video image for possible sentinel nodes. (Figure 5)
Figure 1 Molecular structure of Indocyanin green.
Figure 2 Infra red camera system. Figure 3 Anatomical sites involved.
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plete the neck dissection and identify the SLN of the
contralateral side in one case. It was clear that the
longer the lag time from injection to visualization the
more lymph nodes were identified. A subjective ideal
time was later set at 5 minutes after injection.
In two cases the lymphatic drainage pattern around the
submandibular gland could be identified and followed to
Figure 4 Level IB.
Figure 5 Jugulodigastric lymph nodes with fluorescence.
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two cases demonstrated distinct ICG uptake in the
submandibular gland that did not represent lymphatic
tissue. As soon as more than 5 mm tissue covers the SLN
it will probably hinder the identification of the fluores-
cent tissue.
There is a distinct learning curve involved in the use
and finding the optimal balance between brightness,
infra red and contrast settings with the infra red video
camera.
Direct light like the operating light will interfere with
the picture quality and visualization ability and may
need to be dimmed or switched off in order to optimize
the visualization of fluorescent SLN. Settings on the
video camera may be set in such a way that there the
surgical field and tissues are identifiable on the monitor.
Discussion
The identification of sentinel lymph nodes in the head
and neck area is still controversial although now more
and more used in the clinically N0 neck situation. SLN
biopsy is regarded valuable for two main reasons. One is
the possible better identification of the anatomically first
drainage lymph node in the drainage basin and should
have the highest risk for being the first affected in the
case of metastatic disease. Once the node or nodes are
identified the node can be sent for frozen section and
when positive a complete neck dissection is performed. If
negative the patient received a procedure with lowered
morbidity with a high chance of the neck being treated
effectively and efficiently. Secondly the other alternative
is to progress to a planned neck dissection and merely
mark the SLN and request intensified pathological
workup of the SLN that may lead to an upstaging of the
neck of 34-40% [14,23,24].
Many methods and components have been described
to be used in SLN identification. The first and simplest
of these is methylene blue which can be used as a fluor-
escent component as well. Methylene blue can be com-
bined with
125I as an easier intraoperative protocol with
less radiation exposure [24].
Technesium 99 labelled sulfur colloid (
99 mTcSC)
alone or in combination with methylene blue is probably
the most widely used as it allows one to quantify the
radioactivity picked up on the gamma probe and further
t oh a v eap r eo p e r a t i v ep i c t u r eo ft h ei d e n t i f i e dS L N .
Injection of
99 mTcSC around the primary tumor site is
performed at least 2 hours before or even the afternoon
before surgery the next morning. The injection is
reported to be painful as local anesthesia in the vicinity
should be avoided. Another advantage is the possibility
to perform a scintigraphy beforehand to identify and
localize the SLN before surgery. This may be of great
help where the SLN isolated in an unexpected area.
One of the main disadvantages is the often close
p r o x i m i t yo ft h ep r i m a r yt u m o rt ot h ef i r s tp o t e n t i a l
sentinel node where identification may be difficult [25].
This is especially true in mouth floor tumors and may
Figure 6 Lymph drainage around the submandibular gland.
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the primary tumor and sentinel node.
Use of ICG in sentinel node identification for oro-
pharyngeal cancer has to the authors knowledge not
been published before. There are significant potential
benefits in this new method.
The method is very simple and except for the equip-
ment investment relatively cheap to run due to the rela-
tive small cost of the ICG compound. No pre planning
needed as with conventional Technesium 99 labelled
sulfur colloid and one can start with the sentinel node
identification within seconds after injection. Few adverse
reactions to ICG have been reported, however care
should be taken in patients sensitive to iodide.
Clear visualization is possible if 5 mm or less of tissue
covers the lymph node. Lymph pathways may be visua-
lized that may lead to deeper lying draining lymph
nodes. Uptake of ICG by other tissues like the subman-
dibular gland was noted, but easily distinguished as non
lymphatic tissue. An assistant can hold the infrared
video camera and an area can be explored in real time.
Potential disadvantages are the lack of a pre operative
visualization of potentially affected lymph nodes as with
lymphoscyntography that may lead to larger incisions to
gain access to the affected area, the inability to visualize
the affected sentinel node in the presence of more than
5 mm of soft tissue coverage as well as a learning curve
in the use of the infra red video camera and its settings.
Furthermore no numerical or other quantification exists
to be able to compare different areas of uptake. Green
discoloration of the injected area did not have a marked
influence on the resection of the primary tumor, how-
ever when unclear mucosal disease exists it is suggested
to mark the mucosal resection borders before injection
of the ICG is done.
Conclusion
There are shortcomings in the current traditional ways
of sentinel lymph node detection. Sentinel lymph node
mapping by ICG fluorescence in patients with orophar-
yngeal cancer is a new potential method of demonstrat-
ing the first station lymph drainage basin as well as the
associated lymph drainage patterns as it allows for direct
visualization. Further development with controlled stu-
dies in this field is needed.
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